2,5-Difluorotoluene | CAS:452-67-5

We serve 2,5-Difluorotoluene CAS:452-67-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,5-Difluorotoluene

Product Name: 2,5-Difluorotoluene
Other Name: 1,4-Difluoro-2-methylbenzene
CAS No: 452-67-5
MF: C7H6F2
MW: 128.11900
Density: 1.36
Boiling point: 117ºC (775 mmHg)
Melting point: -35ºC
Flash point: 12ºC
Refractive index: 1.451-1.453
Vapor Pressure: 343mmHg at 25°C
UN Number: UN1993
UN Proper Shipping Name: FLAMMABLE LIQUID, N.O.S.
Transport hazard class: 3
Packing group: II
 
Specification
Appearance: Colorless to light yellow transparent liquid
Purity: ≥98%
Water: ≤0.5%
 
Application: Organic intermediates, pharmaceutical intermediates, agrochemical intermediates.
Package: 25kg/drum, packed in plastic drum or plastic coated iron drum.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 2,5-Difluorotoluene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4-Difluoro-2-methylbenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,5-Difluorotoluene Use and application,1,4-Difluoro-2-methylbenzene technical grade,usp/ep/jp grade.


Related News: In China, Wuhan used to be known as a city of cherry blossoms, an economic engine of the central heartland, and the birthplace of a century-old revolution that brought down the country’s last imperial dynasty.2-(triazol-2-yl)benzoic acid manufacturer The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant’s collection.2-Bromo-4-fluoropyridine supplier The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant’s collection.N-Acetyl-DL-Alanine vendor Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.